Literature DB >> 22654305

Glanzmann's Thrombasthenia: A Rare Cause of Recurrent Profuse Epistaxis.

Mainak Dutta, Soumya Ghatak, Sirshak Dutta, Jayanta Saha, Indranil Sen, Ramanuj Sinha.   

Abstract

Though epistaxis is a commonplace emergency encountered in the Otorhinolaryngology clinic, recurrent, severe and intractable cases are relatively less common. In those cases where no local causes are found that could explain such episodes, systemic causes, including hematological disorders should be considered, and thoroughly explored. However, routine hematological investigations often fail to identify a definite cause. Here we report about a 23 year-old woman presenting with severe recurrent epistaxis due to Glanzmann's thrombasthenia-a rare, autosomal recessive disease. Never before Glanzmann's thrombasthenia has been reported to present with severe epistaxis as its sole feature.

Entities:  

Keywords:  Epistaxis; Glanzmann’s thrombasthenia; Platelet aggregation defect

Year:  2011        PMID: 22654305      PMCID: PMC3136664          DOI: 10.1007/s12288-011-0073-3

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  11 in total

Review 1.  Integrins: versatility, modulation, and signaling in cell adhesion.

Authors:  R O Hynes
Journal:  Cell       Date:  1992-04-03       Impact factor: 41.582

Review 2.  Glanzmann's thrombasthenia: the spectrum of clinical disease.

Authors:  J N George; J P Caen; A T Nurden
Journal:  Blood       Date:  1990-04-01       Impact factor: 22.113

3.  Prevalence and significance of mild bleeding disorders in children with recurrent epistaxis.

Authors:  E Katsanis; K H Luke; E Hsu; M Li; D Lillicrap
Journal:  J Pediatr       Date:  1988-07       Impact factor: 4.406

4.  Epistaxis.

Authors:  P M Stell
Journal:  Clin Otolaryngol Allied Sci       Date:  1977-08

5.  Epistaxis. A clinical study of 1,724 patients.

Authors:  H Juselius
Journal:  J Laryngol Otol       Date:  1974-04       Impact factor: 1.469

6.  A point mutation in the cysteine-rich domain of glycoprotein (GP) IIIa results in the expression of a GPIIb-IIIa (alphaIIbbeta3) integrin receptor locked in a high-affinity state and a Glanzmann thrombasthenia-like phenotype.

Authors:  C Ruiz; C Y Liu; Q H Sun; M Sigaud-Fiks; E Fressinaud; J Y Muller; P Nurden; A T Nurden; P J Newman; N Valentin
Journal:  Blood       Date:  2001-10-15       Impact factor: 22.113

Review 7.  Molecular basis of Glanzmann's Thrombasthenia and current strategies in treatment.

Authors:  S Bellucci; J Caen
Journal:  Blood Rev       Date:  2002-09       Impact factor: 8.250

8.  A single amino acid substitution flanking the fourth calcium binding domain of alpha IIb prevents maturation of the alpha IIb beta 3 integrin complex.

Authors:  D A Wilcox; J L Wautier; D Pidard; P J Newman
Journal:  J Biol Chem       Date:  1994-02-11       Impact factor: 5.157

9.  The formation of Ca++-dependent complexes of platelet membrane glycoproteins IIb and IIIa in solution as determined by crossed immunoelectrophoresis.

Authors:  T J Kunicki; D Pidard; J P Rosa; A T Nurden
Journal:  Blood       Date:  1981-08       Impact factor: 22.113

Review 10.  Glanzmann thrombasthenia.

Authors:  Alan T Nurden
Journal:  Orphanet J Rare Dis       Date:  2006-04-06       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.